Sciteline Partners with Think Research to Connect Patients with Clinical Trials Through its Leading Digital Referral Network

TORONTO, July 19 2021- Sciteline, a company focused on transforming clinical trials through digital software solutions, today announced a partnership with Think Research Corporation to connect patients to clinical trials through its pipeline into Ontario's digital referral network.

Sciteline, a Toronto-based company that uses software to improve clinical trial efficiency and increase patient engagement during recruitment and trial conduct, will now allow senders on the digital referral network to refer patients Into clinical trials. This means more patients across the province, regardless of location, will be able to remotely connect with clinical research teams in a timely and secure manner, improving the diversity of research, all while standardizing best practices.

Sciteline Cofounder Patrick Craib said, "This is a big day for Sciteline, and an even bigger day for removing barriers patients face in getting· access to innovative methods of care and therapeutics in Ontario. For the first time, patients can now be electronically referred directly to a clinical trial as a care option by robust network of physicians and hospitals. This is going to greatly improve access and diversity in clinical research in Ontario, and we hope other provinces will follow Ontario's lead."

Think Research CEO Sachin Aggarwal said "The landscape of clinical research is changing, and it is imperative that we adopt innovative methods to improve the workflow of clinical trials and patient recruitment. Think is pleased to partner with Sciteline to allow more people to participate in clinical trials and streamline the process for both patients and researchers, from screening to follow-ups. This expansion shows the potential of our digital referral network and the ability for it to be scaled across other provinces."

Sciteline continues to build innovative solutions and partner with industry leaders to support access and diversity in clinical research. This partnership builds on Sciteline's ongoing work and suite of products, creating an end-to-end experience for patients and researchers conducting studies.

For more Information: https://www.sciteline.com

For media inquiries, contact:

Chad Walsh, Co-Founder

+1-519-766-3203

chad.walsh@sciteline.com